Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Crane, George E.
1973.
Clinical Psychopharmacology in Its 20th Year.
Science,
Vol. 181,
Issue. 4095,
p.
124.
1973.
Advantages and Risks of Psychopharmacotherapy.
New England Journal of Medicine,
Vol. 289,
Issue. 22,
p.
1201.
Crane, George E.
1973.
Persistent Dyskinesia.
British Journal of Psychiatry,
Vol. 122,
Issue. 569,
p.
395.
Gerlach, Jes
1975.
Long-term effect of perphenazine on the substantia nigra in rats.
Psychopharmacologia,
Vol. 45,
Issue. 1,
p.
51.
McClelland, HA
1976.
Assessment of drugs in schizophrenia. Discussion on assessment of drug‐ induced extrapyramidal reactions..
British Journal of Clinical Pharmacology,
Vol. 3,
Issue. S2,
p.
401.
Nordgren, Lars
1976.
Synpunkter På Diagnostik Och Behandling Av Schizofreni.
Nordisk Psykiatrisk Tidsskrift,
Vol. 30,
Issue. 8,
p.
583.
Gottfries, Carl Gerhard
1976.
Lågtidsbehandling med neuroleptika.
Nordisk Psykiatrisk Tidsskrift,
Vol. 30,
Issue. 7,
p.
491.
1977.
The prevention of tardive dyskinesia.
American Journal of Psychiatry,
Vol. 134,
Issue. 7,
p.
756.
Bassuk, Ellen L.
and
Schoonover, Stephen C.
1977.
The Practitioner’s Guide to Psychoactive Drugs.
p.
77.
Gerlach, J.
Rasmussen, P. T.
Hansen, L.
and
Kristjansen, P.
1977.
Antiparkinsonian agents and long‐term neuroleptic treatment.
Acta Psychiatrica Scandinavica,
Vol. 55,
Issue. 4,
p.
251.
McCreadie, Robin G.
and
MacDonald, Ian M.
1977.
High Dosage Haloperidol in Chronic Schizophrenia.
British Journal of Psychiatry,
Vol. 131,
Issue. 3,
p.
310.
Crane, George E.
1978.
Handbook of Psychopharmacology.
p.
165.
1978.
Withdrawal syndromes associated with antipsychotic drugs.
American Journal of Psychiatry,
Vol. 135,
Issue. 11,
p.
1321.
Stefanis, C.N.
and
Issidorides, M.R.
1979.
Short and long-term effects of neuroleptics in relation to their cellular mechanism of action.
Progress in Neuro-Psychopharmacology,
Vol. 3,
Issue. 1-3,
p.
259.
Gelder, Michael
and
Kolakowska, Tamara
1979.
Variability of response to neuroleptics in schizophrenia: Clinical, pharmacologic, and neuroendocrine correlates.
Comprehensive Psychiatry,
Vol. 20,
Issue. 5,
p.
397.
Zaratzian, V. L.
1980.
Psychotropic drugs—neurotoxicity.
Clinical Toxicology,
Vol. 17,
Issue. 2,
p.
231.
Chan, Caryle H.
Davis, John M.
Smith, Robert C.
and
Reed, Ken
1980.
Tardive Dyskinesia.
p.
511.
1980.
Tardive dyskinesia: summary of a Task Force Report of the American Psychiatric Association. By the Task Force on Late Neurological Effects of Antipsychotic Drugs.
American Journal of Psychiatry,
Vol. 137,
Issue. 10,
p.
1163.
Baldessarini, Ross J.
and
Davis, John M.
1980.
What is the best maintenance dose of neuroleptics in schizophrenia?.
Psychiatry Research,
Vol. 3,
Issue. 2,
p.
115.
1980.
Overview: public health issues in tardive dyskinesia.
American Journal of Psychiatry,
Vol. 137,
Issue. 7,
p.
776.
eLetters
No eLetters have been published for this article.